Information Provided By:
Fly News Breaks for February 20, 2020
SNBR
Feb 20, 2020 | 07:57 EDT
Raymond James analyst Bobby Griffin raised his price target for Sleep Number to $62 from $54 and reaffirmed his Outperform rating, saying the company delivered a "solid" quarter, with sales, EBIT/EBITDA and EPS all exceeding estimates. Griffin tells investors in a research note that he continues to have a favorable view of the company's business model and differentiated product offering, especially as more consumers focus on health and wellness.